In this Issue
- As Trump Takes Office, Impact on Psychedelics Field Remains Unclear
- Psychedelics Advocate Sergey Brin Bags Seat in Billionaire’s Gallery
- When MAHA?
- NIH Freeze Stokes Funding Fears; Might Psychedelics Benefit?
- Psychedelic Power Couple, the Jurvetsons, Talk Trump, Lykos, and Philanthropy at Munich Conference
- Genevieve Jurvetson Hopes to Get MDMA Approved This Year
- J&J Buys Intra-Cellular for $14.6 Billion
- Lykos Provides Update on Board Departures, FDA Meeting, and U.S. Patent Applications
- GH Research Shares Positive Results from Proof of Concept Studies; Provides Update on FDA Clinical Hold
- and more…
***
Sign-in or join Pα+ to continue reading this Issue of the Psychedelic Bulletin…
Independent data-driven reporting, analysis and commentary on the psychedelics space: from business and drug development through to policy reform and culture.
Already a member? Log In
✓ Regular Bulletins covering key topics and trends in the psychedelics space
✓ Regular articles and deep dives across psychedelic research, policy and business
✓ Interviews with insiders
✓ Monthly interactive database and commentary on psychedelic patents
✓ Quick-take analysis of major developments
✓ A Library of primers and explainers
✓ Access to our full back catalogue